Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - CASH FROM OPERATIONS
Cash from Operations URGN - UroGen Pharma Ltd.
-76.4 M
LAST VALUE
5.15%
2 YEAR CAGR
-15.39%
5 YEAR CAGR
-40.45%
10 YEAR CAGR